| Cancer-related molecular mechanisms research | Lifetime | 163 | CN 68 | 99.28 |
| Systemic Lupus Erythematosus Research | Lifetime | 227 | CN 5 | 99.21 |
| MicroRNA in disease regulation | Lifetime | 637 | CN 235 | 98.03 |
| Gut microbiota and health | Lifetime | 630 | CN 65 | 97.96 |
| Anesthesia and Neurotoxicity Research | Lifetime | 444 | CN 22 | 97.26 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 589 | CN 28 | 96.44 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 792 | CN 15 | 97.10 |
| Systemic Sclerosis and Related Diseases | Lifetime | 772 | CN 18 | 95.13 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 190 | CN 8 | 93.88 |
| Liver Diseases and Immunity | Lifetime | 757 | CN 19 | 94.63 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 874 | CN 171 | 89.05 |
| Biomarkers in Disease Mechanisms | Lifetime | 448 | CN 30 | 87.71 |
| Phytochemicals and Medicinal Plants | Lifetime | 906 | CN 38 | 82.31 |
| Natural Compounds in Disease Treatment | Lifetime | 646 | CN 328 | 69.01 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 47 | CN 4 | 98.90 |
| Immune Cell Function and Interaction | 2021-2025 | 161 | CN 36 | 97.56 |
| T-cell and B-cell Immunology | 2021-2025 | 76 | CN 5 | 97.01 |
| Cancer-related molecular mechanisms research | 2021-2025 | 414 | CN 319 | 96.65 |
| Gut microbiota and health | 2021-2025 | 541 | CN 253 | 96.33 |
| Immune Response and Inflammation | 2021-2025 | 130 | CN 48 | 92.26 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | 2021-2025 | 78 | CN 17 | 91.75 |
| Immune cells in cancer | 2021-2025 | 402 | CN 218 | 93.08 |
| interferon and immune responses | 2021-2025 | 208 | CN 116 | 92.04 |
| Inflammasome and immune disorders | 2021-2025 | 216 | CN 108 | 92.54 |
| Cell Adhesion Molecules Research | 2021-2025 | 141 | CN 15 | 88.33 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 706 | CN 41 | 90.45 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 688 | CN 107 | 88.65 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 415 | CN 76 | 85.57 |
| Salivary Gland Disorders and Functions | 2021-2025 | 281 | CN 41 | 85.29 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 108 | CN 42 | 78.16 |
| Adenosine and Purinergic Signaling | 2021-2025 | 563 | CN 136 | 70.82 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 609 | CN 123 | 63.94 |
| Hereditary Neurological Disorders | 2021-2025 | 920 | CN 75 | 55.21 |
| Flavonoids in Medical Research | 2021-2025 | 391 | CN 163 | 50.17 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 722 | CN 125 | 46.87 |
